Crossmark

Efficacy and Safety of Ca2+ Channel α2δ Ligands for the Treatment of Diabetic Peripheral Neuropathic Pain: A Systematic Review and Network Meta-analysis

Crossref DOI link: https://doi.org/10.1007/s40122-025-00789-5

Published Online: 2025-10-28

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Hui

Wang, Yi

Lv, Hongjun

Shi, Bingyin https://orcid.org/0000-0002-7545-7043
Funding

Funding for this research was provided by:

Daiichi Sankyo (China) Holdings Co., Ltd
License Information

Text and Data Mining valid from 2025-10-28

Version of Record valid from 2025-10-28
More Information

Article History

Received: 16 July 2025

Accepted: 10 October 2025

First Online: 28 October 2025

Declarations

:

: The authors (Hui Guo, Yi Wang, Hongjun Lv, Bingyin Shi) declare that they have no competing interests.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

Document is current

Any future updates will be listed below